Adam Steensberg

Adam Steensberg serves as Chief Medical Officer, EVP, Head of Research and Development at Zealand Pharma. Zealand Pharma operates in the research sector with approximately 470.0 employees. The company is headquartered in Copenhagen, Capital Region of Denmark. Zealand Pharma generates annual revenue of 48820000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 947 executive contacts are available in Capital Region of Denmark.
• • Our database includes 201,469 c suite-level executives.

CloudFlare CDN Outlook Microsoft Office 365 CloudFlare Hosting Microsoft Azure Hosting Basis

biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research peptide-based therapeutics innovative drug development obesity treatment rare diseases chronic inflammation metabolic disorders congenital hyperinsulinism short bowel syndrome peptide research drug discovery clinical trials patient-centric treatments strategic collaborations pharmaceutical partnerships healthcare professionals global commercialization orphan drug development metabolic dysfunction weight management glp-1 receptor agonists dual agonists chronic disease management r&d pipeline sustainable practices healthcare innovation patient quality of life therapeutic areas peptide platform advanced candidates healthcare solutions health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Adam Steensberg in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Zealand Pharma.

Adam Steensberg's Position in the MessageCEO Database

• •Adam Steensberg is 1 of 1 verified executive contact we track at Zealand Pharma.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •942 verified executive contacts in Capital Region of Denmark are in the database.
• •7 verified contacts work at research companies in the 470.0 employee range (same size as Zealand Pharma).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Adam Steensberg directly?

Adam Steensberg's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Medical Officer, EVP, Head of Research and Development at Zealand Pharma. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Adam Steensberg work for?

Adam Steensberg is Chief Medical Officer, EVP, Head of Research and Development at Zealand Pharma, a company in the research sector with 470.0 employees. The company is based in Copenhagen, Capital Region of Denmark.

Can I pitch or sell to Adam Steensberg?

As Chief Medical Officer, EVP, Head of Research and Development at Zealand Pharma, Adam Steensberg is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Adam Steensberg directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Adam Steensberg in?

Adam Steensberg works in the research industry as Chief Medical Officer, EVP, Head of Research and Development at Zealand Pharma. MessageCEO provides verified contact information for executives across all major industries.

Is Adam Steensberg's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Adam Steensberg's profile is kept up-to-date with the latest available information.

Last updated: June 21, 2026